Orgenesis Inc. – NASDAQ:ORGS
Orgenesis stock price today
$0.88
-1.96
-69.01%
Financial Health
0
1
2
3
4
5
6
7
8
9
Market closed
Open in 2 days
Orgenesis stock price monthly change
+284.82%
month
Orgenesis stock price quarterly change
+284.82%
quarter
Orgenesis stock price yearly change
+491.67%
year
Orgenesis key metrics
Market Cap | 7.23M |
Enterprise value | 30.97M |
P/E | -2.13 |
EV/Sales | 0.61 |
EV/EBITDA | 4.80 |
Price/Sales | 0.58 |
Price/Book | 1.01 |
PEG ratio | -0.01 |
EPS | -1.1 |
Revenue | -6.37M |
EBITDA | -50.45M |
Income | -35.63M |
Revenue Q/Q | -97.99% |
Revenue Y/Y | -117.77% |
Profit margin | 10.81% |
Oper. margin | -84.41% |
Gross margin | 25.77% |
EBIT margin | -84.41% |
EBITDA margin | 791.73% |
Sign up &
create your own Smart Feed
create your own Smart Feed
Personalize your watchlist with companies you want to keep track of and get notified in the smart feed every time fresh news arrives.
Sign up for freeOrgenesis stock price history
Orgenesis stock forecast
Orgenesis financial statements
| Jun 2023 | 6.97M | -4.12M | -59.17% |
|---|---|---|---|
| Sep 2023 | 110K | 12.65M | 11502.73% |
| Dec 2023 | -13.59M | -34.39M | 252.9% |
| Mar 2024 | 141K | -9.76M | -6925.53% |
| Jun 2023 | 54767000 | 30.80M | 56.24% |
|---|---|---|---|
| Sep 2023 | 45299000 | 32.90M | 72.63% |
| Dec 2023 | 14552000 | 35.53M | 244.19% |
| Mar 2024 | 30920000 | 58.46M | 189.1% |
| Jun 2023 | -5.91M | -1.49M | 4.88M |
|---|---|---|---|
| Sep 2023 | -1.18M | -843K | -3.40M |
| Dec 2023 | -502K | -62K | 1.22M |
| Mar 2024 | -4.44M | -68K | 3.61M |
Orgenesis alternative data
Cell and Gene Therapy
| 21 May 2023 | 57 | 41 |
|---|---|---|
| 28 May 2023 | 56 | 35 |
| 4 Jun 2023 | 56 | 40 |
| 11 Jun 2023 | 57 | 39 |
| 18 Jun 2023 | 62 | 43 |
| 25 Jun 2023 | 63 | 44 |
| 2 Jul 2023 | 70 | 48 |
| 9 Jul 2023 | 63 | 48 |
| 16 Jul 2023 | 59 | 43 |
| 23 Jul 2023 | 70 | 50 |
| 30 Jul 2023 | 68 | 51 |
| 6 Aug 2023 | 62 | 51 |
| 13 Aug 2023 | 58 | 50 |
| 20 Aug 2023 | 54 | 41 |
| 27 Aug 2023 | 58 | 47 |
| 3 Sep 2023 | 66 | 54 |
| 10 Sep 2023 | 51 | 48 |
| 17 Sep 2023 | 69 | 57 |
| 24 Sep 2023 | 65 | 62 |
| 1 Oct 2023 | 56 | 59 |
Orgenesis
| 21 May 2023 | 2 |
|---|---|
| 28 May 2023 | 6 |
| 4 Jun 2023 | 7 |
| 11 Jun 2023 | 0 |
| 18 Jun 2023 | 0 |
| 25 Jun 2023 | 3 |
| 2 Jul 2023 | 3 |
| 9 Jul 2023 | 0 |
| 16 Jul 2023 | 3 |
| 23 Jul 2023 | 3 |
| 30 Jul 2023 | 7 |
| 6 Aug 2023 | 8 |
| 13 Aug 2023 | 0 |
| 20 Aug 2023 | 2 |
| 27 Aug 2023 | 2 |
| 3 Sep 2023 | 7 |
| 10 Sep 2023 | 5 |
| 17 Sep 2023 | 8 |
| 24 Sep 2023 | 8 |
| 1 Oct 2023 | 5 |
Numbers represent search interest relative to the highest point on the chart for the given region and time.
A value of 100 is the peak popularity for the term.
A value of 50 means that the term is half as popular.
A score of 0 means there was not enough data for this term.
What is job openings count?
| Aug 2023 | 6 |
|---|---|
| Sep 2023 | 5 |
| Oct 2023 | 4 |
| Nov 2023 | 3 |
| Dec 2023 | 2 |
| Jan 2024 | 1 |
| Feb 2024 | 1 |
| Apr 2024 | 1 |
| May 2024 | 2 |
| Jun 2024 | 2 |
| Jul 2024 | 0 |
| Dec 2024 | 0 |
| Jan 2025 | 0 |
| Feb 2025 | 0 |
| May 2025 | 0 |
| Jul 2025 | 0 |
| Aug 2025 | 0 |
| Aug 2023 | 167 |
|---|---|
| Sep 2023 | 167 |
| Oct 2023 | 167 |
| Nov 2023 | 167 |
| Dec 2023 | 167 |
| Jan 2024 | 167 |
| Feb 2024 | 167 |
| Mar 2024 | 167 |
| Apr 2024 | 167 |
| May 2024 | 146 |
| Jun 2024 | 146 |
| Jul 2024 | 146 |
Orgenesis other data
3.39%
-6.66%
of ORGS is owned by hedge funds
748.39K
-1.47M
shares is hold by hedge funds
What is insider trading?
| Period | Buy | Sel |
|---|---|---|
| Sep 2023 | 130000 | 0 |
| Oct 2023 | 31703 | 0 |
| Nov 2023 | 75421 | 0 |
| Dec 2023 | 16016 | 0 |
| Jan 2024 | 112000 | 0 |
| Feb 2024 | 10100 | 0 |
| Apr 2024 | 20000 | 20000 |
| Jun 2024 | 10000 | 10000 |
| Patent |
|---|
Application Filling date: 8 Mar 2022 Issue date: 8 Sep 2022 |
Application Filling date: 16 May 2022 Issue date: 1 Sep 2022 |
Application Filling date: 6 Mar 2019 Issue date: 10 Jun 2021 |
Application Filling date: 6 Oct 2020 Issue date: 20 May 2021 |
Grant Filling date: 7 Nov 2019 Issue date: 13 Apr 2021 |
Grant Filling date: 25 Apr 2018 Issue date: 16 Mar 2021 |
Application Filling date: 4 Apr 2019 Issue date: 25 Feb 2021 |
Grant Filling date: 29 Nov 2018 Issue date: 2 Jun 2020 |
| Quarter | Transcript |
|---|---|
| Q1 2023 11 Aug 2023 | Q1 2023 Earnings Call Transcript |
| Q4 2022 21 Mar 2023 | Q4 2022 Earnings Call Transcript |
| Q3 2022 13 Nov 2022 | Q3 2022 Earnings Call Transcript |
| Q2 2022 16 Aug 2022 | Q2 2022 Earnings Call Transcript |
| Insider | Compensation |
|---|---|
Ms. Vered Caplan M.Sc. (1969) Chairperson of the Board, Chief Executive Officer & Pres | $865,640 |
Mr. Neil T. Reithinger CPA (1970) Chief Financial Officer, Sec. & Treasurer | $455,230 |
-
What's the price of Orgenesis stock today?
One share of Orgenesis stock can currently be purchased for approximately $0.88.
-
When is Orgenesis's next earnings date?
Unfortunately, Orgenesis's (ORGS) next earnings date is currently unknown.
-
Does Orgenesis pay dividends?
No, Orgenesis does not pay dividends.
-
How much money does Orgenesis make?
Orgenesis has a market capitalization of 7.23M and it's past years’ income statements indicate that its last revenue has decreased compared to the previous period by 98.53% to 530K US dollars.
-
What is Orgenesis's stock symbol?
Orgenesis Inc. is traded on the NASDAQ under the ticker symbol "ORGS".
-
What is Orgenesis's primary industry?
Company operates in the Healthcare sector and Biotechnology industry.
-
How do i buy shares of Orgenesis?
Shares of Orgenesis can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
-
Who are Orgenesis's key executives?
Orgenesis's management team includes the following people:
- Ms. Vered Caplan M.Sc. Chairperson of the Board, Chief Executive Officer & Pres(age: 56, pay: $865,640)
- Mr. Neil T. Reithinger CPA Chief Financial Officer, Sec. & Treasurer(age: 55, pay: $455,230)
-
How many employees does Orgenesis have?
As Jul 2024, Orgenesis employs 146 workers, which is 13% less then previous quarter.
-
When Orgenesis went public?
Orgenesis Inc. is publicly traded company for more then 13 years since IPO on 13 Mar 2012.
-
What is Orgenesis's official website?
The official website for Orgenesis is orgenesis.com.
-
Where are Orgenesis's headquarters?
Orgenesis is headquartered at 20271 Goldenrod Lane, Germantown, MD.
-
How can i contact Orgenesis?
Orgenesis's mailing address is 20271 Goldenrod Lane, Germantown, MD and company can be reached via phone at +48 06596404.
Orgenesis company profile:
Orgenesis Inc.
orgenesis.comExchange:
NASDAQ
Full time employees:
146
Industry:
Biotechnology
Sector:
Healthcare
Orgenesis Inc., a biotech company, focusing on cell and gene therapies worldwide. The company develops a Point of Care (POCare) platform that includes a pipeline of licensed POCare therapeutics that are processed and produced in closed automated POCare technology systems across a collaborative POCare network. It focuses on autologous therapies, with processes and systems that are developed for each therapy using a closed and automated processing system approach that is validated for compliant production near the patient at their point of care for treatment of the patient. The company was formerly known as Business Outsourcing Service, Inc. and changed its name to Orgenesis Inc. in August 2011. Orgenesis Inc. was incorporated in 2008 and is based in Germantown, Maryland.
20271 Goldenrod Lane
Germantown, MD 20876
Germantown, MD 20876
CIK: 0001460602
ISIN: US68619K2042
CUSIP: 68619K204
